Cargando…
sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt/PCP-JNK pathway
Doxorubicin (Dox) is an effective chemotherapy drug against a wide range of cancers, including both hematological and solid tumors. However, the serious cardiotoxic effect restricted its clinical application. We previously have illuminated the protective role of canonical Wnt/β-catenin signaling in...
Autores principales: | Hu, Yue-huai, Liu, Jie, Lu, Jing, Wang, Pan-xia, Chen, Jian-xing, Guo, Ying, Han, Fang-hai, Wang, Jun-jian, Li, Wei, Liu, Pei-qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608092/ https://www.ncbi.nlm.nih.gov/pubmed/32238888 http://dx.doi.org/10.1038/s41401-020-0364-z |
Ejemplares similares
-
Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2
por: Bao, Haili, et al.
Publicado: (2020) -
Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR-1a-3p/sFRP1/Wnt/PCP-JNK Pathway
por: Zang, Tongtong, et al.
Publicado: (2022) -
EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines
por: Liu, Yuting, et al.
Publicado: (2020) -
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
por: Caldwell, G M, et al.
Publicado: (2006) -
The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma
por: Kang, Pengcheng, et al.
Publicado: (2014)